MedTrace Logo

EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV

NCT05412017 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-02-07

No results posted yet for this study

Summary

The research project aims to understand how pharmacies can be involved in the identification and treatment of hepatitis C (hep C). The study will look at the effectiveness of hep C testing and treatment through pharmacies with support from the Cool Aid Community Health Centre (CACHC). The study will also evaluate the readiness of pharmacies to take on these extra tasks at the pharmacy. This information will be used to develop future strategies to better detect, treat and prevent hep C.

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

Hepatitis C Point of Care Testing and Treatment

Pharmacy led hepatitis C point of care testing

Sponsors & Collaborators

  • Cool Aid Community Health Centre

    lead OTHER

Principal Investigators

  • Chris Fraser, MD · Medical Director

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-13
Primary Completion
2023-07-30
Completion
2023-07-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05412017 on ClinicalTrials.gov